Typical Rett Syndrome in a young boy with hemizygous c.316C>T mutation in MECP2 gene

Mutations in the Methyl-CpG-binding protein 2 (MECP2) gene have been implicated in the etiology of Rett syndrome (RTT), a neurodevelopmental disorder that primarily affects girls. MECP2 mutations in males, once thought to be lethal, are now recognized with a broad spectrum of clinical manifestations. Here we report a 3-year-old boy who presented with developmental problems and regression and eventually was diagnosed with RTT that genetic analysis revealed to be a hemizygous c.316C>T missense mutation in the MECP2 gene suggesting somatic mosaicism with the normal 46,XY karyotype. DNA analysis of the patient’s mother showed this either to be a de novo mutation or a case of gonadal mosaicism. To the best of our knowledge, this is the first case report of RTT in a young boy with a hemizygous c.316C>T mutation in the MECP2 gene.

PDF

___

1. Neul JL, Kaufmann WE, Glaze DG, Christodoulou J, Clarke AJ, Bahi-Buisson N, et al; RettSearch Consortium. Rett syndrome: revised diagnostic criteria and nomenclature. Ann Neurol 2010; 68:944-950.

2. Budden SS, Dorsey HC, Steiner RD. Clinical profile of a male with Rett syndrome. Brain Dev 2005; 27(Suppl 1):S69-S71.

3. Dayer AG, Bottani A, Bouchardy I, Fluss J, Antonarakis SE, Haenggeli CA, et al. MECP2 mutant allele in a boy with Rett syndrome and his unaffected heterozygous mother. Brain Dev 2007; 29:47-50.

4. Leonard H, Silberstein J, Falk R, Houwink-Manville I, Ellaway C, Raffaele LS, et al. Occurrence of Rett syndrome in boys. J Child Neurol 2001; 16:333-338.

5. Masuyama T, Matsuo M, Jing JJ, Tabara Y, Kitsuki K, Yamagata H, et al. Classic Rett syndrome in a boy with R133C mutation of MECP2. Brain Dev 2005; 27:439-442.

6. Pieras JI, Munoz-Cabello B, Borrego S, Marcos I, Sanchez J, Madruga M, et al. Somatic mosaicism for Y120X mutation in the MECP2 gene causes atypical Rett syndrome in a male. Brain Dev 2011; 33:608-611.

7. Topcu M, Akyerli C, Sayi A, Toruner GA, Kocoglu SR, Cimbis M, et al. Somatic mosaicism for a MECP2 mutation associated with classic Rett syndrome in a boy. Eur J Hum Genet 2002; 10:77-81.

8. Zeev BB, Yaron Y, Schanen NC, Wolf H, Brandt N, Ginot N, et al. Rett syndrome: clinical manifestations in males with MECP2 mutations. J Child Neurol 2002; 17:20-24.

9. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY. Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2. Nat Genet 1999; 23:185-188.

10. Nussbaum RL, McInnes RR, Willard HF (editors). Thompson & Thompson Genetics in Medicine. Seventh Ed. Philadelphia: Saunders Elsevier, 2007.

11. Campos M Jr, Abdalla CB, dos Santos AV, Pestana CP, dos Santos JM, Santos-Reboucas CB, et al. A MECP2 mutation in a highly conserved aminoacid causing mental retardation in a male. Brain Dev 2009; 31:176-178.

12. Campos M Jr, Pestana CP, dos Santos AV, Ponchel F, Churchman S, Abdalla-Carvalho CB, et al. A MECP2 missense mutation within the MBD domain in a Brazilian male with autistic disorder. Brain Dev 2011; 33:807-809.

13. Kudo S, Nomura Y, Segawa M, Fujita N, Nakao M, Dragich J, et al. Functional analyses of MeCP2 mutations associated with Rett syndrome using transient expression systems. Brain Dev 2001; 23 (Suppl 1):S165-173.

14. Yusufzai TM, Woffle AP. Functional consequences of Rett syndrome mutations on human MeCP2. Nucleic Acids Res 2000; 28: 4172-4179.

15. Akalin I, Yararbas K, Akgul N, Babaoglu E, Akay GG, Dyer S, et al. del5p/dup5q in a ‘cri du chat’ patient without parental chromosomal rearrangement. Am J Med Genet A 2006; 140:1016-1020.